{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T03:00:12Z","timestamp":1771729212946,"version":"3.50.1"},"reference-count":259,"publisher":"Elsevier","isbn-type":[{"value":"9780443432408","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010690","name":"American University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010690","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.podrm.2025.12.004","type":"book-chapter","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T12:59:28Z","timestamp":1767877168000},"page":"77-154","source":"Crossref","is-referenced-by-count":0,"title":["Rosuvastatin calcium: A comprehensive profile"],"prefix":"10.1016","author":[{"given":"Amany A.","family":"Aboomeirah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Maher","family":"Abdeldayem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan Mohamed El-Said","family":"Azzazy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1567-5688(03)00004-7","article-title":"Comparative pharmacology of rosuvastatin","volume":"4","author":"McTaggart","year":"2003","journal-title":"Atheroscler. Suppl"},{"issue":"14","key":"10.1016\/bs.podrm.2025.12.004_bib2","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2165\/00003495-200262140-00008","article-title":"Rosuvastatin","volume":"62","author":"Carswell","year":"2002","journal-title":"Drugs"},{"issue":"14","key":"10.1016\/bs.podrm.2025.12.004_bib3","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/bs.podrm.2025.12.004_bib4","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1067\/mhj.2002.129312","article-title":"Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomized, double-blind, 52-week trial","volume":"144","author":"Brown","year":"2002","journal-title":"Am. Heart J."},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib5","first-page":"3987065","article-title":"Comparative lipid-lowering\/increasing efficacy of 7 statins in patients with dyslipidemia, cardiovascular diseases, or diabetes mellitus: systematic review and network meta-analyses of 50 randomized controlled trials","volume":"2020","author":"Zhang","year":"2020","journal-title":"Cardiovasc. Ther"},{"issue":"7","key":"10.1016\/bs.podrm.2025.12.004_bib6","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199908123410707","article-title":"Drug treatment of lipid disorders","volume":"341","author":"Knopp","year":"1999","journal-title":"N. Engl. J. Med."},{"issue":"20","key":"10.1016\/bs.podrm.2025.12.004_bib7","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary prevention study group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/bs.podrm.2025.12.004_bib8","unstructured":"Rosuvastatin | C22H28FN3O6S | CID 446157 - PubChem. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Rosuvastatin#section=Biologic-Description (Accessed 11\u00a0June\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib9","unstructured":"Crestor, Ezallor Sprinkle (rosuvastatin) dosing, indications, interactions, adverse effects, and more.\u00a0https:\/\/reference.medscape.com\/drug\/crestor-ezallor-sprinkle-rosuvastatin-342467 (Accessed 30 December\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib10","article-title":"Rosuvastatin-laden nanofibrous patches for effective treatment of corneal ulcer in experimental animals","volume":"94","author":"Helmy","year":"2024","journal-title":"J. Drug. Deliv. Sci. Technol"},{"key":"10.1016\/bs.podrm.2025.12.004_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4137\/CMC.S4324","article-title":"Rosuvastatin: a review of the pharmacology and clinical effectiveness in cardiovascular disease","volume":"6","author":"Luvai","year":"2012","journal-title":"Clin. Med. Insights. Cardiol"},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib12","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/sj.bjp.0704070","article-title":"A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid","volume":"133","author":"Stalker","year":"2001","journal-title":"Br. J. Pharmacol"},{"issue":"5","key":"10.1016\/bs.podrm.2025.12.004_bib13","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2125.2002.01688.x","article-title":"Pharmacodynamic effects and pharmacokinetics of a new HMG-CoA reductase inhibitor, rosuvastatin, after morning or evening administration in healthy volunteers","volume":"54","author":"Martin","year":"2002","journal-title":"Br. J. Clin. Pharmacol"},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0021-9150(00)80175-6","article-title":"Single- and multiple-dose pharmacokinetics and safety of the new HMG-CoA reductase inhibitor ZD4522","volume":"151","author":"Warwick","year":"2000","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/bs.podrm.2025.12.004_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0002-9149(01)01454-0","article-title":"Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor","volume":"87","author":"McTaggart","year":"2001","journal-title":"Am. J. Cardiol"},{"key":"10.1016\/bs.podrm.2025.12.004_bib16","unstructured":"A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin - PubMed.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/12211221\/ (Accessed 13 June\u00a02024)."},{"issue":"11","key":"10.1016\/bs.podrm.2025.12.004_bib17","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1016\/S0149-2918(03)80336-3","article-title":"Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers","volume":"25","author":"Martin","year":"2003","journal-title":"Clin. Ther"},{"issue":"10","key":"10.1016\/bs.podrm.2025.12.004_bib18","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/ajhp\/62.10.1033","article-title":"Efficacy and safety of rosuvastatin in treatment of dyslipidemia","volume":"62","author":"Mckenney","year":"2005","journal-title":"Am. J. Health. Syst. Pharm"},{"key":"10.1016\/bs.podrm.2025.12.004_bib19","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.14.04078","article-title":"Higher cardiovascular disease risks in people living with HIV: a systematic review and meta-analysis","volume":"14","author":"Zhu","year":"2024","journal-title":"J. Glob. Health"},{"issue":"14","key":"10.1016\/bs.podrm.2025.12.004_bib20","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012241","article-title":"HIV infection and incidence of cardiovascular diseases: an analysis of a large healthcare database","volume":"8","author":"Alonso","year":"2019","journal-title":"J. Am. Heart Assoc"},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/anie.200460852","article-title":"Chemoenzymatic synthesis of building blocks for statin side chains","volume":"44","author":"M\u00fcller","year":"2005","journal-title":"Angew. Chem. Int. Ed."},{"issue":"29","key":"10.1016\/bs.podrm.2025.12.004_bib22","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1016\/S0040-4039(00)74684-3","article-title":"New chiral blocks for introducing the side chain of HMG-CoA reductase inhibitors","volume":"33","author":"Urabe","year":"1992","journal-title":"Tetrahedron Lett"},{"issue":"10","key":"10.1016\/bs.podrm.2025.12.004_bib23","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1246\/cl.1987.1923","article-title":"A novel method for the in situ generation of alkoxydialkylboranes and their use in the selective preparation of 1,3-syn diols","volume":"16","author":"Chen","year":"1987","journal-title":"Chem. Lett"},{"issue":"10","key":"10.1016\/bs.podrm.2025.12.004_bib24","first-page":"1523","article-title":"Efficient synthesis of (3R,5S)-3,5,6-trihydroxyhexanoic acid derivative as a chiral side chain of statins","author":"Choi","year":"2008","journal-title":"Synlett"},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0968-0896(96)00248-9","article-title":"Synthesis and biological activity of methanesulfonamide pyrimidine- and N-methanesulfonyl pyrrole-substituted 3,5-dihydroxy-6-heptenoates, a novel series of HMG-CoA reductase inhibitors","volume":"5","author":"Watanabe","year":"1997","journal-title":"Bioorg. Med. Chem"},{"issue":"8","key":"10.1016\/bs.podrm.2025.12.004_bib26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2174\/138527210791111858","article-title":"Historic overview and recent advances in the synthesis of super-statins","volume":"14","author":"Casar","year":"2010","journal-title":"Curr. Org. Chem"},{"key":"10.1016\/bs.podrm.2025.12.004_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2022.132717","article-title":"An efficient, cyanide free total synthesis of rosuvastatin calcium","volume":"111","author":"Vempala","year":"2022","journal-title":"Tetrahedron"},{"key":"10.1016\/bs.podrm.2025.12.004_bib28","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jct.2015.11.019","article-title":"Solubility of rosuvastatin calcium in different neat solvents at different temperatures","volume":"94","author":"Alshora","year":"2016","journal-title":"J. Chem. Thermodyn"},{"key":"10.1016\/bs.podrm.2025.12.004_bib29","unstructured":"Rosuvastatin Manufacturers in india, Rosuvastatin Calcium Exporters, Manufacturers.\u00a0https:\/\/www.tivansciences.com\/rosuvastatin-calcium-manufacturers.html (Accessed 16 June\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib30","unstructured":"Rosuvastatin | C22H28FN3O6S | ChemSpider.\u00a0https:\/\/www.chemspider.com\/Chemical-Structure.393589.html (Accessed 16 June\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib31","unstructured":"Rosuvastatin.\u00a0https:\/\/www.drugfuture.com\/chemdata\/rosuvastatin.html (Accessed 16 June\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib32","unstructured":"Rosuvastatin Calcium - LKT Labs.\u00a0https:\/\/lktlabs.com\/product\/rosuvastatin-calcium\/ (Accessed 16 June\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib33","unstructured":"(PDF) Design, fabrication and evaluation of rosuvastatin pharmacosome - a novel sustained release drug delivery system.\u00a0https:\/\/www.researchgate.net\/publication\/311674376_Design_fabrication_and_evaluation_of_rosuvastatin_pharmacosome_-_a_novel_sustained_release_drug_delivery_system (Accessed 22 July\u00a02024)."},{"issue":"6","key":"10.1016\/bs.podrm.2025.12.004_bib34","doi-asserted-by":"crossref","first-page":"790","DOI":"10.4274\/tjps.galenos.2021.62333","article-title":"Cocrystal construction between rosuvastatin calcium and L-asparagine with enhanced solubility and dissolution rate","volume":"18","author":"Vemuri","year":"2021","journal-title":"Turkish J. Pharm. Sci."},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265263","article-title":"Design, development, and characterization of amorphous rosuvastatin calcium tablets","volume":"17","author":"Gonz\u00e1lez","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/bs.podrm.2025.12.004_bib36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jphotochem.2012.11.008","article-title":"A study of photodegradation of drug rosuvastatin calcium in solid state and solution under UV and visible light irradiation: the influence of certain dyes as efficient stabilizers","volume":"252","author":"Litvi\u0107","year":"2013","journal-title":"J. Photochem. Photobiol. A Chem"},{"key":"10.1016\/bs.podrm.2025.12.004_bib37","doi-asserted-by":"crossref","unstructured":"R. Gonz\u00e1, M.A. Ngeles Pe\u00f1aid, N.S.\u00a0Torres, G. Torrado, Design, development, and characterization of amorphous rosuvastatin calcium tablets, 2022. https:\/\/doi.org\/10.1371\/journal.pone.0265263.","DOI":"10.1371\/journal.pone.0265263"},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.5530\/ijpi.2020.2.35","article-title":"Stabilization of rosuvastatin calcium formulation by prevention of intermolecular esterification: an experimental design","volume":"10","author":"Khan","year":"2020","journal-title":"Int. J. Pharm. Investig"},{"key":"10.1016\/bs.podrm.2025.12.004_bib39","unstructured":"A. S. Issa, Study of the effect of light and heat on rosuvastatin calcium stability,\u00a02010. pp. 19\u201326."},{"issue":"4","key":"10.1016\/bs.podrm.2025.12.004_bib40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/10408347.2018.1439364","article-title":"Analytical methods for the determination of rosuvastatin in pharmaceutical formulations and biological fluids: a critical review","volume":"48","author":"\u00c2ngelo","year":"2018","journal-title":"Crit. Rev. Anal. Chem"},{"key":"10.1016\/bs.podrm.2025.12.004_bib41","first-page":"411","article-title":"Spectrophotometric determination of rosuvastatin calcium in tablets","volume":"62","author":"Uyar","year":"2007","journal-title":"Pharmazie"},{"key":"10.1016\/bs.podrm.2025.12.004_bib42","article-title":"Development and validation of extractive spectrophotometric method for determination of rosuvastatin calcium in pharmaceutical dosage forms","author":"Prajapati","year":"2010","journal-title":"J. Pharm. Res."},{"key":"10.1016\/bs.podrm.2025.12.004_bib43","unstructured":"View of development of the spectrophotometric method for the determination of rosuvastatin in tablets by using bromophenol blue.\u00a0https:\/\/journals.uran.ua\/sr_pharm\/article\/view\/277461\/272707 (Accessed 22 June\u00a02024)."},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib44","doi-asserted-by":"crossref","DOI":"10.1590\/s2175-97902017000300075","article-title":"Spectrophotometric determination of rosuvastatin in pharmaceutical formulations using quinalizarin","volume":"53","author":"Lima","year":"2017","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/bs.podrm.2025.12.004_bib45","unstructured":"R.Y. Lahare, A.N. Phuge, A.L. Gite, A.K. Jadhav, A review on ultraviolet spectrophotometric determination of rosuvastatin calcium in marketed formulation, Accessed\u00a005\u00a0July\u00a02024. [Online]. Available: www.ijpab.com."},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/1752-153X-5-57","article-title":"Novel microwell-based spectrophotometric assay for determination of atorvastatin calcium in its pharmaceutical formulations","volume":"5","author":"Wani","year":"2011","journal-title":"Chem. Cent. J."},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib47","first-page":"28","article-title":"A review on chromatographic method for estimation of Rosuvastatin calcium","volume":"3","author":"Rajput","year":"2018","journal-title":"Int. J. Res. Pharm. Pharm. Sci. 28 Int. J. Res. Pharm. Pharm. Sci."},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib48","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1570-0232(02)00088-0","article-title":"Quantification of rosuvastatin in human plasma by automated solid-phase extraction using tandem mass spectrometric detection","volume":"772","author":"Hull","year":"2002","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"7","key":"10.1016\/bs.podrm.2025.12.004_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23071548","article-title":"Hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry for therapeutic drug monitoring of metformin and Rosuvastatin in human plasma","volume":"23","author":"Antonopoulos","year":"2018","journal-title":"Molecules"},{"issue":"3\u20134","key":"10.1016\/bs.podrm.2025.12.004_bib50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jpba.2005.05.005","article-title":"Simultaneous determination of rosuvastatin and fenofibric acid in human plasma by LC-MS\/MS with electrospray ionization: assay development, validation and application to a clinical study","volume":"39","author":"Trivedi","year":"2005","journal-title":"J. Pharm. Biomed. Anal"},{"key":"10.1016\/bs.podrm.2025.12.004_bib51","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1201\/9781003091226-2","article-title":"Basic principles and fundamental aspects of mass spectrometry","author":"Ahamad","year":"2022","journal-title":"Mass. Spectrom. Food Anal"},{"issue":"1\u20132","key":"10.1016\/bs.podrm.2025.12.004_bib52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jchromb.2007.05.012","article-title":"Liquid chromatography\/negative ion electrospray tandem mass spectrometry method for the quantification of rosuvastatin in human plasma: application to a pharmacokinetic study","volume":"856","author":"Gao","year":"2007","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci."},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.59566\/IJBS.2006.2217","article-title":"Immunoassay methods and their applications in pharmaceutical analysis: basic methodology and recent advances","volume":"2","author":"Darwish","year":"2006","journal-title":"Int. J. Biomed. Sci."},{"key":"10.1016\/bs.podrm.2025.12.004_bib54","doi-asserted-by":"crossref","DOI":"10.1186\/1752-153X-5-38","article-title":"Generation of polyclonal antibody with high avidity to rosuvastatin and its use in development of highly sensitive ELISA for determination of rosuvastatin in plasma","author":"Darwish","year":"2011","journal-title":"Chem Cent J"},{"issue":"5","key":"10.1016\/bs.podrm.2025.12.004_bib55","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/dta.328","article-title":"Validated enzyme-linked immunosorbent assay for determination of rosuvastatin in plasma at picogram level","volume":"5","author":"Darwish","year":"2013","journal-title":"Drug. Test. Anal"},{"issue":"5","key":"10.1016\/bs.podrm.2025.12.004_bib56","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jpba.2005.01.043","article-title":"Validation of quantitative NMR","volume":"38","author":"Malz","year":"2005","journal-title":"J. Pharm. Biomed. Anal"},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib57","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pnmrs.2010.05.001","article-title":"Quantitative NMR spectroscopy in pharmaceutical applications","volume":"57","author":"Holzgrabe","year":"2010","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc"},{"key":"10.1016\/bs.podrm.2025.12.004_bib58","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jpba.2016.02.016","article-title":"Quantitative analysis of highly similar salvianolic acids with 1H qNMR for quality control of traditional Chinese medicinal preparation Salvianolate Lyophilized Injection","volume":"124","author":"Chen","year":"2016","journal-title":"J. Pharm. Biomed. Anal"},{"key":"10.1016\/bs.podrm.2025.12.004_bib59","unstructured":"qNMR--a versatile concept for the validation of natural product reference compounds - PubMed.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/11704959\/ (Accessed 19 July\u00a02024)."},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib60","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/np0497301","article-title":"Quantitative 1H NMR: development and potential of a method for natural products analysis","volume":"68","author":"Pauli","year":"2005","journal-title":"J. Nat. Prod"},{"issue":"4","key":"10.1016\/bs.podrm.2025.12.004_bib61","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1021\/np060535r","article-title":"A routine experimental protocol for qHNMR illustrated with taxol","volume":"70","author":"Pauli","year":"2007","journal-title":"J. Nat. Prod"},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00216-012-5777-1","article-title":"Determination of standard sample purity using the high-precision 1H NMR process","volume":"403","author":"Schoenberger","year":"2012","journal-title":"Anal. Bioanal. Chem"},{"issue":"9","key":"10.1016\/bs.podrm.2025.12.004_bib63","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3390\/molecules22091517","article-title":"The application of quantitative 1H NMR for the determination of orlistat in tablets","volume":"22","author":"Sun","year":"2017","journal-title":"Mol"},{"key":"10.1016\/bs.podrm.2025.12.004_bib64","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.talanta.2012.05.062","article-title":"Absolute quantification for benzoic acid in processed foods using quantitative proton nuclear magnetic resonance spectroscopy","volume":"99","author":"Ohtsuki","year":"2012","journal-title":"Talanta"},{"issue":"5","key":"10.1016\/bs.podrm.2025.12.004_bib65","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jpba.2005.01.050","article-title":"Quantitative NMR spectroscopy--applications in drug analysis","volume":"38","author":"Holzgrabe","year":"2005","journal-title":"J. Pharm. Biomed. Anal"},{"key":"10.1016\/bs.podrm.2025.12.004_bib66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.copbio.2013.08.004","article-title":"Universal quantitative NMR analysis of complex natural samples","volume":"25","author":"Simmler","year":"2014","journal-title":"Curr. Opin. Biotechnol"},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib67","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0731-7085(99)00156-9","article-title":"Quantitative determination of azathioprine in tablets by 1H NMR spectroscopy","volume":"21","author":"G\u00f6ger","year":"1999","journal-title":"J. Pharm. Biomed. Anal"},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib68","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3906\/kim-2007-7","article-title":"The application of qNMR for the determination of rosuvastatin in tablet form","volume":"45","author":"Dikmen","year":"2021","journal-title":"Turkish J. Chem"},{"issue":"5","key":"10.1016\/bs.podrm.2025.12.004_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9734\/AIR\/2015\/19843","article-title":"Development and validation of a complexometric titration method for the determination of rosuvastatin calcium in raw material","volume":"5","author":"Baldut","year":"2015","journal-title":"Adv. Res."},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib70","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1134\/S1061934815110040","article-title":"Determination of residual amounts of Rosuvastatin Calcium on the surfaces of pharmaceutical equipment by HPLC and luminescence","volume":"71","author":"Yegorova","year":"2016","journal-title":"J. Anal. Chem"},{"key":"10.1016\/bs.podrm.2025.12.004_bib71","unstructured":"A.M. Badawey, N. M. Mostafa, N. T. Lamie, A. El-Aleem AEB, Stability-indicating methods for the determination of rosuvastatin in the presence of its oxidative degradation products,\u00a02012, https:\/\/doi.org\/10.4172\/scientificreports.322."},{"issue":"7","key":"10.1016\/bs.podrm.2025.12.004_bib72","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.3390\/molecules18077711","article-title":"Analytical study for the charge-transfer complexes of rosuvastatin calcium with \u03c0-acceptors","volume":"18","author":"Alzoman","year":"2013","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/bs.podrm.2025.12.004_bib73","doi-asserted-by":"crossref","first-page":"288","DOI":"10.38124\/IJISRT20JUL097","article-title":"Degradation study of different brands of rosuvastatin calcium tablet in Bangladesh using UV spectrophotometer","volume":"5","author":"Nahar","year":"2020","journal-title":"Int. J. Innov. Sci. Res. Technol"},{"issue":"42","key":"10.1016\/bs.podrm.2025.12.004_bib74","first-page":"11","article-title":"Development of the spectrophotometric method for the determination of rosuvastatin in tablets by using bromophenol blue","volume":"2","author":"Halka","year":"2023","journal-title":"Sci. Pharm. Sci."},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib75","first-page":"89","article-title":"Simple UV spectrophotometric determination of rosuvastatin calcium in pure form and in pharmaceutical formulations","volume":"6","author":"Gupta","year":"2009","journal-title":"E-Journal Chem"},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.31024\/ajpp.2018.4.1.8","article-title":"Determination of rosuvastatin calcium in bulk and pharmaceutical dosage forms by using UV-Spectrophotometric method","volume":"4","author":"Singh","year":"2018","journal-title":"Asian J. Pharm. Pharmacol"},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib77","first-page":"46","article-title":"Extractive spectrophotometric methods for the determination of rosuvastatin calcium in pure form and in pharmaceutical formulations by using safranin O and methylene blue","volume":"4","author":"Krishna","year":"2007","journal-title":"E-Journal Chem"},{"key":"10.1016\/bs.podrm.2025.12.004_bib78","unstructured":"(PDF) Spectrophotometric determination of rosuvastatin calcium in pure form and pharmaceutical formulations by the oxidation using iodine and formation triiodide complex in acetonitrile.\u00a0https:\/\/www.researchgate.net\/publication\/285964651_Spectrophotometric_determination_of_rosuvastatin_calcium_in_pure_form_and_pharmaceutical_formulations_by_the_oxidation_using_iodine_and_formation_triiodide_complex_in_acetonitrile (Accessed 22 June\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib79","unstructured":"(PDF) Spectrophotometric determination of rosuvastatin in pure form and pharmaceutical formulations through ion-pair complex formation using bromocresol green.\u00a0https:\/\/www.researchgate.net\/publication\/285245234_Spectrophotometric_determination_of_rosuvastatin_in_pure_form_and_pharmaceutical_formulations_through_ion-pair_complex_formation_using_bromocresol_green (Accessed 22 June\u00a02024)."},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib80","article-title":"Indirect oxygen flask-atomic absorption spectrometric determination of rosuvastatin calcium","volume":"1","author":"Mohamed Hassouna","year":"2017","journal-title":"Biomed. J. Sci. Tech. Res."},{"key":"10.1016\/bs.podrm.2025.12.004_bib81","unstructured":"M. L. \u00c2ngelo, An\u00e1lise qu\u00edmico-farmac\u00eautica de rosuvastatina c\u00e1lcica comprimido e c\u00e1psula. Universidade Federal de Alfenas, Dec. 9, 2016. Accessed: Dec. 26, 2025. [Online]. Available: https:\/\/repositorio.unifal-mg.edu.br\/handle\/123456789\/1128."},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib82","doi-asserted-by":"crossref","first-page":"587","DOI":"10.52711\/0974-360X.2022.00096","article-title":"Green solvent assisted UV-spectrophotometric method for estimation of rosuvastatin in bulk and pharmaceutical dosage forms","volume":"15","author":"Patil","year":"2022","journal-title":"Res. J. Pharm. Technol"},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib83","first-page":"7","article-title":"Saudi journal of medical and pharmaceutical sciences analytical method development and validation for the estimation of rosuvastatin calcium in raw material and tablet formulation by UV spectrometric method","volume":"2","author":"Sailaja","year":"2016","journal-title":"Saudi J. Med. Pharm. Sci."},{"key":"10.1016\/bs.podrm.2025.12.004_bib84","unstructured":"P. Pannure, V.B. Jadhav, A. Jain, Development and validation of spectrophotometric method for the determination of rosuvastatin calcium in solid dosage form and pharmaceutical formulation,\u00a0Int. J. Thesis Proj. Diss., 6, pp. 31\u201337, Accessed\u00a005 July\u00a02024. [Online]. Available: www.researchpublish.com."},{"key":"10.1016\/bs.podrm.2025.12.004_bib85","unstructured":"Quantitative estimation of Rosuvastatin in bulk and tablet dosage form by using area under curve method.\u00a0https:\/\/jpbs-online.com\/issueforpublication.aspx?Article=22_pdf (Accessed 05 July\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib86","unstructured":"K.G. Sankar, G. Arati Prakash, K. Akanksha Valmik, M. Rushikesh Keru Associate Professor, Method development and validation of rosuvastatin calcium by using Uv-spectrophotometry,\u00a0Int. J. Pharm. Res. Appl., 8, p. 611, https:\/\/doi.org\/10.35629\/7781\u20130805611615."},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib87","first-page":"109","article-title":"A validated analytical method development for rosuvastatin calcium by difference spectroscopy","volume":"12","author":"Kujur","year":"2018","journal-title":"Asian J. Pharm. Res. Dev."},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib88","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10895-012-1115-4","article-title":"Determination of rosuvastatin in urine by spectrofluorimetry after liquid-liquid extraction and derivatization in acidic medium","volume":"23","author":"Braga","year":"2013","journal-title":"J. Fluoresc"},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib89","first-page":"73","article-title":"Analytical method development for rosuvastatin and irbesartan through simultaneous equation by UV-Spectroscopy","volume":"19","author":"Sahu","year":"2020","journal-title":"Int.\u00a0J. Pharm. & Pharm. Res."},{"key":"10.1016\/bs.podrm.2025.12.004_bib90","unstructured":"V. V. Rajkondwar, P. Maini, and M. Vishwakarma, Characterization and method development for estimation and validation of rosuvastatin calcium by UV-visible spectrophotometry, 2009."},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib91","doi-asserted-by":"crossref","first-page":"135","DOI":"10.5958\/2231-5675.2017.00021.7","article-title":"Development and validation of UV spectrophotometric method for the simultaneous estimation of rosuvastatin and ezetimibe in pharmaceutical dosage form","volume":"7","author":"Monika","year":"2017","journal-title":"Asian J. Pharm. Anal"},{"key":"10.1016\/bs.podrm.2025.12.004_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2024.125123","article-title":"Eco-friendly second derivative synchronous fluorescence spectroscopic method for simultaneous determination of rosuvastatin and ezetimibe in pharmaceutical capsules","volume":"325","author":"Ramzy","year":"2025","journal-title":"Spectrochim. Acta Part. A Mol. Biomol. Spectrosc"},{"key":"10.1016\/bs.podrm.2025.12.004_bib93","unstructured":"(PDF) Development and validation of UV spectrophotometric method for simultaneous estimation of propranolol hydrochloride and rosuvastatin calcium in bulk drug and pharmaceutical dosage form. https:\/\/www.researchgate.net\/publication\/286013118_Development_and_validation_of_UV_spectrophotometric_method_for_simultaneous_estimation_of_propranolol_hydrochloride_and_rosuvastatin_calcium_in_bulk_drug_and_pharmaceutical_dosage_form (Accessed 24 December\u00a02024)."},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib94","doi-asserted-by":"crossref","DOI":"10.1515\/phys-2024-0090","article-title":"Smart mathematically filtered UV spectroscopic methods for quality assurance of rosuvastatin and valsartan from formulation","volume":"22","author":"Attimarad","year":"2024","journal-title":"Open. Phys"},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43094-024-00698-y","article-title":"In vitro and in vivo evaluation of crosslinked wound dressing loaded with combined rosuvastatin calcium and levofoxacin simultaneously determined by eco-friendly spectrophotometric method","volume":"10","author":"Abd El\u2011Fattah","year":"2024","journal-title":"Futur. J. Pharm. Sci."},{"key":"10.1016\/bs.podrm.2025.12.004_bib96","unstructured":"R.R. Sevda, A.S. Ravetkar, P.J. Shirote, UV Spectrophotometric estimation of Rosuvastatin calcium and fenofibrate in bulk drug and dosage form using simultaneous equation method,\u00a0Int. J. ChemTech Res. CODEN, 3, 2, pp. 629\u2013635."},{"key":"10.1016\/bs.podrm.2025.12.004_bib97","unstructured":"(PDF) Development and validation of derivative spectroscopic method for the simultaneous estimation of rosuvastatin calcium and fenofibrate in Tablet.\u00a0https:\/\/www.researchgate.net\/publication\/281106363_Development_and_Validation_of_Derivative_Spectroscopic_Method_for_the_Simultaneous_Estimation_of_Rosuvastatin_Calcium_and_Fenofibrate_in_Tablet (Accessed 22 June\u00a02024)."},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib98","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3329\/sjps.v4i1.8868","article-title":"Simultaneous estimation of rosuvastatin calcium and fenofibrate in bulk and in tablet dosage Form by UV-Spectrophotometry and RP-HPLC","volume":"4","author":"Karunakaran","year":"2011","journal-title":"Stamford J. Pharm. Sci."},{"key":"10.1016\/bs.podrm.2025.12.004_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.119163","article-title":"Univariate and multivariate assisted spectrophotometric methods for determination of rosuvastatin calcium and fenofibrate in bulk powders and tablets along with their degradation products","volume":"248","author":"Hegazy","year":"2021","journal-title":"Spectrochim. Acta Part. A Mol. Biomol. Spectrosc"},{"key":"10.1016\/bs.podrm.2025.12.004_bib100","unstructured":"(PDF) Simultaneous estimation for rosuvastatin calcium and aspirin from capsule dosage forms by first order derivative spectroscopic method. https:\/\/www.researchgate.net\/publication\/259288721_Simultaneous_estimation_for_rosuvastatin_calcium_and_aspirin_from_capsule_dosage_forms_by_first_order_derivative_spectroscopic_method (Accessed 22 June\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib101","unstructured":"(PDF) Spectrophotometric estimation of rosuvastatin calcium and glimepiride in tablet dosage form.\u00a0https:\/\/www.researchgate.net\/publication\/264460806_Spectrophotometric_Estimation_of_Rosuvastatin_Calcium_and_Glimepiride_in_Tablet_Dosage_Form (Accessed 22 June\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib102","unstructured":"(PDF) Derivative spectrophotometric determination of rosuvastatin calcium and fenofibrate in tablet dosage form.\u00a0https:\/\/www.researchgate.net\/publication\/245470703_DERIVATIVE_SPECTROPHOTOMETRIC_DETERMINATION_OF_ROSUVASTATIN_CALCIUM_AND_FENOFIBRATE_IN_TABLET_DOSAGE_FORM (Accessed 22 June\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib103","unstructured":"Q-absorbance and multicomponent UV - Spectrophotometric methods for simultaneous estimation of rosuvastatin calcium and fenofibrate in pharmaceutical formulation.\u00a0https:\/\/www.researchgate.net\/publication\/288281517_Q-absorbance_and_multicomponent_UV_-_Spectrophotometric_methods_for_simultaneous_estimation_of_rosuvastatin_calcium_and_fenofibrate_in_pharmaceutical_formulation (Accessed 22 June\u00a02024)."},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib104","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1155\/2012\/913913","article-title":"Spectrofluorometric determination of certain antihyperlipidemic agents in bulk and pharmaceutical preparations","volume":"27","author":"El-Bagary","year":"2012","journal-title":"Spectrosc. (N. Y.)"},{"issue":"5","key":"10.1016\/bs.podrm.2025.12.004_bib105","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.52711\/0974-360X.2022.00341","article-title":"Development and validation of a solvent extraction UV spectrophotometric method for the estimation of rosuvastatin calcium and telmisartan in combined dosage form","volume":"15","author":"Jose","year":"2022","journal-title":"Res. J. Pharm. Technol"},{"key":"10.1016\/bs.podrm.2025.12.004_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2023.122588","article-title":"Green-assisted spectrophotometric techniques utilizing mathematical and ratio spectra manipulations to resolve severely overlapped spectra of a cardiovascular pharmaceutical mixture","volume":"295","author":"Fawzy","year":"2023","journal-title":"Spectrochim. Acta Part. A Mol. Biomol. Spectrosc"},{"issue":"4","key":"10.1016\/bs.podrm.2025.12.004_bib107","article-title":"Spectrophotometric and chromatographic estimation of Telmisartan and Rosuvastatin in pharmaceutical dosage form","volume":"10","author":"Delhiraj","year":"2019","journal-title":"Int. J. Chem. Pharm. Sci."},{"key":"10.1016\/bs.podrm.2025.12.004_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2024.124164","article-title":"Development of a highly sensitive and green first-derivative synchronous fluorescence spectroscopic method for the simultaneous quantification of telmisartan and rosuvastatin: greenness metric assessment and application to a pharmacokinetic study in rats","volume":"314","author":"Ramzy","year":"2024","journal-title":"Spectrochim. Acta. A. Mol. Biomol. Spectrosc"},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib109","first-page":"15","article-title":"Spectrophotometric absorption factor method development and validation for estimation of Rosuvastatin calcium and telmisartan in solid dosage form","volume":"2","author":"Doshi","year":"2010","journal-title":"J. Chem. Pharm. Res."},{"issue":"10","key":"10.1016\/bs.podrm.2025.12.004_bib110","doi-asserted-by":"crossref","DOI":"10.1002\/bio.4928","article-title":"Continuous wavelet transform as a signal processing technique for spectrofluorimetric analysis of Rosuvastatin and losartan: greenness and blueness assessment","volume":"39","author":"Abduljabbar","year":"2024","journal-title":"Luminescence"},{"issue":"6","key":"10.1016\/bs.podrm.2025.12.004_bib111","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/10408347.2017.1332973","article-title":"Statins determination: a review of electrochemical techniques","volume":"47","author":"Antal","year":"2017","journal-title":"Crit. Rev. Anal. Chem"},{"key":"10.1016\/bs.podrm.2025.12.004_bib112","doi-asserted-by":"crossref","DOI":"10.1080\/10408347.2024.2420820","article-title":"Electroanalysis of statin drugs: a review on the electrochemical sensor architectures ranging from classical to modern systems","author":"Martins de Oliveira","year":"2024","journal-title":"Crit. Rev. Anal. Chem"},{"key":"10.1016\/bs.podrm.2025.12.004_bib113","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2147\/IJN.S287665","article-title":"Improved pharmacodynamic potential of rosuvastatin by self-nanoemulsifying drug delivery system: an in vitro and in vivo evaluation","volume":"16","author":"Verma","year":"2021","journal-title":"Int. J. Nanomed"},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13036-024-00406-7","article-title":"Enhancing osteogenic differentiation of dental pulp stem cells through rosuvastatin loaded niosomes optimized by Box-Behnken design and modified by hyaluronan: a novel strategy for improved efficiency","volume":"18","author":"Sadeghi Ghadi","year":"2024","journal-title":"J. Biol. Eng."},{"key":"10.1016\/bs.podrm.2025.12.004_bib115","unstructured":"(PDF) Formulation and evaluation of rosuvastatin oral dispersible tablet under a creative commons attribution 4.0.\u00a0https:\/\/www.researchgate.net\/publication\/340262020_FORMULATION_AND_EVALUATION_OF_ROSUVASTATIN_ORAL_DISPERSIBLE_TABLET_under_a_Creative_Commons_Attribution_40 (Accessed 16 June\u00a02024)."},{"issue":"10","key":"10.1016\/bs.podrm.2025.12.004_bib116","doi-asserted-by":"crossref","first-page":"4784","DOI":"10.5958\/0974-360X.2020.00841.0","article-title":"Formulation and evaluation of rosuvastatin-calcium drug transdermal patch","volume":"13","author":"Lakshmi","year":"2020","journal-title":"Res. J. Pharm. Technol"},{"key":"10.1016\/bs.podrm.2025.12.004_bib117","doi-asserted-by":"crossref","first-page":"1220357","DOI":"10.3389\/fmolb.2023.1220357","article-title":"Chitosan, polyethylene oxide\/polycaprolactone electrospun core\/shell nanofibrous mat containing rosuvastatin as a novel drug delivery system for enhancing human mesenchymal stem cell osteogenesis","volume":"10","author":"Ghasemvand","year":"2023","journal-title":"Front. Mol. Biosci"},{"key":"10.1016\/bs.podrm.2025.12.004_bib118","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jsps.2019.03.002","article-title":"Directly compressed rosuvastatin calcium tablets that offer hydrotropic and micellar solubilization for improved dissolution rate and extent of drug release","volume":"27","author":"Butt","year":"2019","journal-title":"Saudi Pharm. J."},{"issue":"20","key":"10.1016\/bs.podrm.2025.12.004_bib119","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1039\/c3ay40863a","article-title":"Electrochemical behaviour and voltammetric determination of rosuvastatin calcium in pharmaceutical preparations using a square-wave voltammetric method","volume":"5","author":"Altin\u00f6z","year":"2013","journal-title":"Anal. Methods"},{"issue":"6","key":"10.1016\/bs.podrm.2025.12.004_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/mps5060090","article-title":"An efficient, simultaneous electrochemical assay of rosuvastatin and ezetimibe from human urine and serum samples","volume":"5","author":"Karadurmus","year":"2022","journal-title":"Methods Protoc"},{"key":"10.1016\/bs.podrm.2025.12.004_bib121","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.snb.2015.04.085","article-title":"Electrochemical determination of rosuvastatin calcium in pharmaceutical and human body fluid samples using a composite of vertically aligned carbon nanotubes and graphene oxide as the electrode material","volume":"218","author":"Silva","year":"2015","journal-title":"Sens. Actuators B Chem"},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib122","doi-asserted-by":"crossref","DOI":"10.1063\/5.0099661","article-title":"A simple electrochemical method for determination of rosuvastatin calcium in cholesterol-lowering medical products","volume":"2610","author":"Nhu-Trang","year":"2022","journal-title":"AIP Conf. Proc"},{"key":"10.1016\/bs.podrm.2025.12.004_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.talo.2024.100376","article-title":"Development of nanomaterial-supported molecularly imprinted polymer\/receptor-like sensor for the detection of rosuvastatin from binary mixtures","volume":"10","author":"Gharibi","year":"2024","journal-title":"Talanta Open"},{"issue":"7","key":"10.1016\/bs.podrm.2025.12.004_bib124","first-page":"579","article-title":"Differential pulse voltammetric determination of rosuvastatin via glassy carbon electrode","volume":"62","author":"Karadurmus","year":"2017","journal-title":"Rev. Roum. Chim"},{"key":"10.1016\/bs.podrm.2025.12.004_bib125","article-title":"Differential pulse polarographic behavior and determination of rosuvastatin in pure form and in pharmaceutical preparations using a static mercury drop electrode","author":"Ramadan","year":"2014","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/bs.podrm.2025.12.004_bib126","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.microc.2019.04.035","article-title":"Facile synthesis of novel nanocomposite prepared from spinel copper ferrite and reduced graphene oxide in the presence of anti-fouling agent diethyl ammonium acid sulphate for ultrasensitive detection of rosuvastatin in human plasma","volume":"147","author":"El-Wekil","year":"2019","journal-title":"Microchem. J."},{"issue":"5","key":"10.1016\/bs.podrm.2025.12.004_bib127","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3390\/inventions8050111","article-title":"Quantification of statins in pharmaceutical products using screen-printed sensors based of multi-walled carbon nanotubes and gold nanoparticles","volume":"8","author":"Ro\u015fca","year":"2023","journal-title":"Inventions"},{"key":"10.1016\/bs.podrm.2025.12.004_bib128","doi-asserted-by":"crossref","DOI":"10.1039\/C8RA10415H","article-title":"Enhancement effect of reduced graphene oxide and silver nanocomposite supported on poly brilliant blue platform for ultra-trace voltammetric analysis of rosuvastatin in tablets and human plasma \u2020","author":"El-Zahry","year":"2019","journal-title":"RSC Adv"},{"issue":". 1","key":"10.1016\/bs.podrm.2025.12.004_bib129","article-title":"Determination of rosuvastatin in pharmaceutical formulations by capillary zone electrophoresis","volume":"66","author":"S\u00fcsl\u00fc","year":"2007","journal-title":"Chromatographia"},{"key":"10.1016\/bs.podrm.2025.12.004_bib130","article-title":"Implementation of two sustainable chromatographic methods for the simultaneous micro-quantitation and impurity profiling of metformin and rosuvastatin in recently approved fixed dose pills: greenness and whiteness studies","volume":"30","author":"Elbordiny","year":"2022","journal-title":"Sustain. Chem. Pharm"},{"issue":"3\u20134","key":"10.1016\/bs.podrm.2025.12.004_bib131","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1365\/s10337-009-1432-1","article-title":"Fast analysis of statins in pharmaceuticals by MEKC","volume":"71","author":"Dami\u0107","year":"2010","journal-title":"Chromatographia"},{"key":"10.1016\/bs.podrm.2025.12.004_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2024.112177","article-title":"Rosuvastatin calcium electrochemical sensor based on a sulfur doped graphitic carbon nitride modified glassy carbon electrode: a metal free analysis approach","volume":"207","author":"Sharma","year":"2024","journal-title":"Microchem. J."},{"issue":"20","key":"10.1016\/bs.podrm.2025.12.004_bib133","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.3390\/ma17205016","article-title":"Potentiometric electronic tongue for the evaluation of multiple-unit pellet sprinkle formulations of rosuvastatin calcium","volume":"17","author":"Cal","year":"2024","journal-title":"Mater"},{"issue":"4","key":"10.1016\/bs.podrm.2025.12.004_bib134","doi-asserted-by":"crossref","first-page":"108","DOI":"10.22270\/ajprd.v12i4.1449","article-title":"A review on the HPLC method development and validation studies of combined dosage form of rosuvastatin and ezetimibe","volume":"12","author":"Chandran","year":"2024","journal-title":"Asian J. Pharm. Res. Dev."},{"key":"10.1016\/bs.podrm.2025.12.004_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2024.110422","article-title":"Advances in the detection of emerging contaminant metformin: a critical review","volume":"200","author":"Wu","year":"2024","journal-title":"Microchem. J."},{"key":"10.1016\/bs.podrm.2025.12.004_bib136","article-title":"A review on various HPLC and spectrophotometric methods for determination of rosuvastatin calcium and fenofibrate in combined dosage forms","author":"Usharani","year":"2014","journal-title":"Indian J. Res. Pharm. Biotechnol"},{"key":"10.1016\/bs.podrm.2025.12.004_bib137","article-title":"Telmisartan and rosuvastatin:\u00a0a review on the analytical methods for the individual and combined dosage forms. 1","author":"Jose","year":"2020","journal-title":"Int. J. Res. Anal. Rev."},{"key":"10.1016\/bs.podrm.2025.12.004_bib138","article-title":"Rosuvastatin calcium quantification in rat serum with the aid of RP-HPLC: method development and validation","author":"Smitha","year":"2015","journal-title":"J Pharm Biol Sci"},{"key":"10.1016\/bs.podrm.2025.12.004_bib139","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejpb.2016.10.022","article-title":"Improved anti-hyperlipidemic activity of rosuvastatin calcium via lipid nanoparticles: pharmacokinetic and pharmacodynamic evaluation","volume":"110","author":"Dudhipala","year":"2017","journal-title":"Eur. J. Pharm. Biopharm"},{"key":"10.1016\/bs.podrm.2025.12.004_bib140","doi-asserted-by":"crossref","unstructured":"S. Nazir, Z. Iqbal, F. Nasir, Impact of menopause on pharmacokinetics of rosuvastatin compared with premenopausal women,\u00a0Eur. J. Drug. Metab. Pharmacokinet 41. https:\/\/doi.org\/10.1007\/s13318\u2013015-0285\u20132.","DOI":"10.1007\/s13318-015-0285-2"},{"key":"10.1016\/bs.podrm.2025.12.004_bib141","unstructured":"European Pharmacopoeia 2015: Supplement 8.3 W\/ 8.4 and 8.5: European Pharmacopoeia: 9789287177308: Amazon.com: Books. https:\/\/www.amazon.com\/European-Pharmacopoeia-2015-Supplement-8\u20133\/dp\/9287177309\/ref=sr_1_5?dib=eyJ2IjoiMSJ9.JXCi0Tg4HDHgaKMu-WrgyM5PANgmuMZmfG_4CmU3JZa3Lbut0fZKtDzWkzDst-tSkMd-nWH0Mb2DQw-Ew_87N9EK835bIS6KCWfK4PX5MwaHZcdrBc-yg7wa629RgFkUv8ZQwaJCy2_BcX63fQsTFlAsjd5Mr4LyEL26DQTMAHY.9BeHjgAQ0BNECsPXB1iUhdW9qm85PR38G-VpXhXtqYA&dib_tag=se&qid=1720382902&refinements=p_27%3AEuropean+Pharmacopoeia&s=books&sr=1\u20135 (Accessed 07\u00a0July\u00a02024)."},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib142","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3797\/scipharm.1410-09","article-title":"Development of a stability-indicating stereoselective method for quantification of the enantiomer in the drug substance and pharmaceutical dosage form of rosuvastatin calcium by an enhanced approach","volume":"83","author":"Reddy","year":"2014","journal-title":"Sci. Pharm"},{"key":"10.1016\/bs.podrm.2025.12.004_bib143","unstructured":"(PDF) Development and validation of RP-HPLC method for estimation of Rosuvastatin calcium solid dispersions tablet. https:\/\/www.researchgate.net\/publication\/267450062_Development_and_validation_of_RP-HPLC_method_for_estimation_of_Rosuvastatin_calcium_solid_dispersions_tablet (Accessed 15 July\u00a02024)."},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib144","doi-asserted-by":"crossref","first-page":"303","DOI":"10.25258\/ijpqa.11.3.1","article-title":"Implementation of quality by design approach to the analytical method development and validation for the estimation of rosuvastatin calcium","volume":"11","author":"Dhamdhere","year":"2020","journal-title":"Int. J. Pharm. Qual. Assur"},{"key":"10.1016\/bs.podrm.2025.12.004_bib145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.22159\/ijcr.2020v4i4.128","article-title":"Stability-indicating method development and validation for the estimation of rosuvastatin calcium in pharmaceutical dosage form by reverse phase-high performance liquid chromatography","author":"Pimpale","year":"2020","journal-title":"Int. J. Chem. Res."},{"issue":"11,","key":"10.1016\/bs.podrm.2025.12.004_bib146","first-page":"150","article-title":"Analytical quality by design approach for estimating rosuvastatin calcium in pharmaceutical formulation by green HPLC method: Ecologically evaluated and stability-indicating","volume":"11","author":"Rathinam","year":"2021","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/bs.podrm.2025.12.004_bib147","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.colsurfb.2013.08.025","article-title":"Self nanoemulsifying drug delivery system (SNEDDS) of Rosuvastatin calcium: Design, formulation, bioavailability and pharmacokinetic evaluation","volume":"112","author":"Balakumar","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"9","key":"10.1016\/bs.podrm.2025.12.004_bib148","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/bmc.611","article-title":"Determination of rosuvastatin in rat plasma by HPLC: validation and its application to pharmacokinetic studies","volume":"20","author":"Kumar","year":"2006","journal-title":"Biomed. Chromatogr"},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib149","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/chromsci\/bms105","article-title":"Determination of rosuvastatin at picogram level in serum by fluorimetric derivatization with 9-anthryldiazomethane using HPLC","volume":"51","author":"Caglar","year":"2013","journal-title":"J. Chromatogr. Sci."},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib150","first-page":"24","article-title":"Method development and validation for simultaneous estimation of rosuvastatin calcium and ezetimibe in pharmaceutical dosage form by rp-hplc","volume":"2","author":"M","year":"2012","journal-title":"Int. Res. J. Pharm. Appl. Sci."},{"issue":"4","key":"10.1016\/bs.podrm.2025.12.004_bib151","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijcas.2013.04.006","article-title":"RP-HPLC method for simultaneous estimation of rosuvastatin and ezetimibe from their combination tablet dosage form","volume":"4","author":"Beludari","year":"2013","journal-title":"Int. J. Chem. Anal. Sci."},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib152","first-page":"974","article-title":"Development and validation of reversed-phase HPLC method for simultaneous estimation of rosuvastatin and fenofibrate in tablet dosage form","volume":"2","author":"Kumar Gv","year":"2016","journal-title":"Int. J. PharmTech Res. CODEN IJPRIF ISSN"},{"key":"10.1016\/bs.podrm.2025.12.004_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123160","article-title":"Stability-indicating RP-HPLC assay of three novel oral anticoagulants binary mixtures with rosuvastatin calcium: Application to pharmaceutical preparations and human plasma","volume":"1193","author":"Hamdy","year":"2022","journal-title":"J. Chromatogr. B"},{"issue":"5-s","key":"10.1016\/bs.podrm.2025.12.004_bib154","doi-asserted-by":"crossref","first-page":"76","DOI":"10.22270\/jddt.v10i5-s.4341","article-title":"Method development and validation for multicomponent analysis of rosuvastatin calcium and losartan potassium in bulk drug by RP-HPLC","volume":"10","author":"Kumar","year":"2020","journal-title":"J. Drug. Deliv. Ther"},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib155","doi-asserted-by":"crossref","DOI":"10.3390\/ph13020032","article-title":"Gr\u0430di\u0435nt HPLC m\u0435th\u043ed f\u043er simult\u0430n\u0435\u043eus d\u0435t\u0435rmin\u0430ti\u043en \u043ef \u0415ight s\u0430rt\u0430n \u0430nd st\u0430tin drugs in th\u0435ir pur\u0435 \u0430nd d\u043es\u0430g\u0435 f\u043erms","volume":"13","author":"Z\u0430r\u0435h","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/bs.podrm.2025.12.004_bib156","unstructured":"(PDF) High performance liquid chromatographic method validation for determination of rosuvastatin calcium in tablet dosage forms.\u201d https:\/\/www.researchgate.net\/publication\/326224323_High_performance_liquid_chromatographic_method_validation_for_determination_of_rosuvastatin_calcium_in_tablet_dosage_forms (Accessed 15 July\u00a02024)."},{"issue":"103","key":"10.1016\/bs.podrm.2025.12.004_bib157","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1556\/JPC.18.2005.3.4","article-title":"Determination of rosuvastatin calcium in its bulk drug and pharmaceutical preparations by high-performance thin-layer chromatography","volume":"18","author":"Sane","year":"2005","journal-title":"J. Planar Chromatogr. - Mod. TLC"},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib158","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3797\/scipharm.1201-09","article-title":"Development and validation of a stability-indicating RP-UPLC method for determination of rosuvastatin and related substances in pharmaceutical dosage form","volume":"80","author":"Trivedi","year":"2012","journal-title":"Sci. Pharm"},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib159","first-page":"1308","article-title":"Development and validation of rp-hplc method for the estimation of rosuvastatin in bulk and pharmaceutical dosage form","volume":"8","author":"Rao","year":"2010","journal-title":"Int. J. Chem. Sci."},{"key":"10.1016\/bs.podrm.2025.12.004_bib160","unstructured":"(PDF) A new validated RP-HPLC method for determination of Rosuvastatin calcium in bulk and pharmaceutical dosage form.\u201d https:\/\/www.researchgate.net\/publication\/268271307_A_new_validated_RP-HPLC_method_for_determination_of_Rosuvastatin_calcium_in_bulk_and_pharmaceutical_dosage_form (Accessed 15 July\u00a02024)."},{"issue":"4","key":"10.1016\/bs.podrm.2025.12.004_bib161","doi-asserted-by":"crossref","DOI":"10.59566\/IJBS.2011.7283","article-title":"Validated high-performance liquid chromatographic method for the estimation of rosuvastatin calcium in bulk and pharmaceutical formulations","volume":"7","author":"Ashour","year":"2011","journal-title":"Int. J. Biomed. Sci."},{"key":"10.1016\/bs.podrm.2025.12.004_bib162","unstructured":"Validated rp-hplc method for determination of rosuvastatin calcium in bulk and pharmaceutical formulation | international Journal of pharmaceutical sciences and research.\u00a0https:\/\/ijpsr.com\/bft-article\/validated-rp-hplc-method-for-determination-of-rosuvastatin-calcium-in-bulk-and-pharmaceutical-formulation\/ (Accessed 24 December\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib163","unstructured":"M.E.-K. Hassouna, Stability indicating new RP-HPLC method for the determination of rosuvastatin calcium in pure and tablets dosage forms,\u00a0Jan. 2017, Accessed\u00a016 July\u00a02024. [Online]. Available: https:\/\/www.academia.edu\/88022965\/Stability_Indicating_New_RP_HPLC_Method_for_the_Determination_of_Rosuvastatin_Calcium_in_Pure_and_Tablets_Dosage_Forms."},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib164","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1515\/gps-2017-0023","article-title":"Development and validation of a green RP-HPLC method for the analysis of rosuvastatin: A step towards making liquid chromatography environmentally benign","volume":"7","author":"Haq","year":"2018","journal-title":"Green. Process. Synth"},{"issue":"15","key":"10.1016\/bs.podrm.2025.12.004_bib165","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1080\/10826076.2013.828305","article-title":"Selective chromatographic methods for the determination of Rosuvastatin calcium in the presence of its acid degradation products","volume":"37","author":"Mostafa","year":"2014","journal-title":"J. Liq. Chromatogr. Relat. Technol"},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib166","doi-asserted-by":"crossref","first-page":"52","DOI":"10.5155\/eurjchem.10.1.52-56.1815","article-title":"Simultaneous determination of bisoprolol fumarate and rosuvastatin calcium in a new combined formulation by validated RP-HPLC","volume":"10","author":"Zaki","year":"2019","journal-title":"Eur. J. Chem"},{"key":"10.1016\/bs.podrm.2025.12.004_bib167","unstructured":"Development and validation of hptlc method for estimation of rosuvastatin calcium in bulk and pharmaceutical dosage forms | Request PDF. https:\/\/www.researchgate.net\/publication\/286977780_Development_and_validation_of_hptlc_method_for_estimation_of_rosuvastatin_calcium_in_bulk_and_pharmaceutical_dosage_forms (Accessed 24 December\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib168","unstructured":"Development and validation of RP-HPLC method for determination of Rosuvastatin Calcium in bulk and pharmaceutical dosage form. https:\/\/www.researchgate.net\/publication\/281495811_Development_and_validation_of_RP-HPLC_method_for_determination_of_Rosuvastatin_Calcium_in_bulk_and_pharmaceutical_dosage_form (Accessed 24 December\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib169","unstructured":"H.A. Raj, S.J. Rajput, J.B. Dave, C.N. Patel, Development and validation of two chromatographic stability-indicating methods for determination of rosuvastatin in pure form and pharmaceutical preparation,\u00a0Int. J. ChemTech Res. CODEN (USA, 1, 3, pp. 677\u2013689."},{"issue":"5","key":"10.1016\/bs.podrm.2025.12.004_bib170","doi-asserted-by":"crossref","first-page":"592","DOI":"10.4103\/0250-474X.78526","article-title":"A new improved RP-HPLC method for assay of rosuvastatin calcium in tablets","volume":"72","author":"Kaila","year":"2010","journal-title":"Indian. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/bs.podrm.2025.12.004_bib171","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.5958\/0974-360X.2020.00515.6","article-title":"Development and validation of a new improved RP-HPLC method for estimation of rosuvastatin calcium in pharmaceutical dosage form","volume":"13","author":"Jana","year":"2020","journal-title":"Res. J. Pharm. Technol"},{"key":"10.1016\/bs.podrm.2025.12.004_bib172","doi-asserted-by":"crossref","first-page":"156","DOI":"10.22159\/ajpcr.2024.v17i5.50225","article-title":"Degradation estimation of rosuvastatin calcium in pharmaceutical tablet formulation","volume":"17","author":"JANA","year":"2024","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"10.1016\/bs.podrm.2025.12.004_bib173","doi-asserted-by":"crossref","first-page":"S1378","DOI":"10.1016\/j.arabjc.2012.03.001","article-title":"Chemometric technique for the optimization of chromatographic system: simultaneous HPLC determination of rosuvastatin, telmisartan, ezetimibe and atorvastatin used in combined cardiovascular therapy","volume":"9","author":"Sree Janardhanan","year":"2016","journal-title":"Arab. J. Chem"},{"key":"10.1016\/bs.podrm.2025.12.004_bib174","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ancr.2016.11.002","article-title":"Structural identification and estimation of rosuvastatin calcium related impurities in rosuvastatin calcium tablet dosage form","volume":"12","author":"Kishore","year":"2017","journal-title":"Anal. Chem. Res."},{"issue":"9\u201310","key":"10.1016\/bs.podrm.2025.12.004_bib175","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.jchromb.2011.01.004","article-title":"Simultaneous determination of rosuvastatin and atorvastatin in human serum using RP-HPLC\/UV detection: Method development, validation and optimization of various experimental parameters","volume":"879","author":"Shah","year":"2011","journal-title":"J. Chromatogr. B"},{"issue":"9","key":"10.1016\/bs.podrm.2025.12.004_bib176","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.52711\/0974-360X.2024.00668","article-title":"RP-HPLC method development and validation for simultaneous estimation of rosuvastatin calcium and teneligliptin hydrobromide hydrate in synthetic mixture","volume":"17","author":"J. Vyas","year":"2024","journal-title":"Res. J. Pharm. Technol"},{"issue":"8","key":"10.1016\/bs.podrm.2025.12.004_bib177","doi-asserted-by":"crossref","DOI":"10.1002\/sscp.202400101","article-title":"Concepts for a new rapid and simple HPLC method for simultaneous determination of rosuvastatin and perindopril in dosage forms","volume":"7","author":"Piponski","year":"2024","journal-title":"Sep. Sci. Plus"},{"issue":"11","key":"10.1016\/bs.podrm.2025.12.004_bib178","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1002\/bmc.692","article-title":"Simultaneous quantitation of rosuvastatin and gemfibrozil in human plasma by high-performance liquid chromatography and its application to a pharmacokinetic study","volume":"20","author":"Vittal","year":"2006","journal-title":"Biomed. Chromatogr"},{"issue":"12","key":"10.1016\/bs.podrm.2025.12.004_bib179","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1007\/s00044-012-9997-x","article-title":"Simultaneous LC determination of rosuvastatin, lisinopril, captopril, and enalapril in API, pharmaceutical dosage formulations, and human serum","volume":"21","author":"Arayne","year":"2012","journal-title":"Med. Chem. Res."},{"issue":"6","key":"10.1016\/bs.podrm.2025.12.004_bib180","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/cjoc.201190226","article-title":"Validated method for the simultaneous determination of lisinopril, pravastatin, atorvastatin and rosuvastatin in API, formulations and human serum by RP-HPLC","volume":"29","author":"Najma","year":"2011","journal-title":"Chin. J. Chem"},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib181","article-title":"Development and validation of rp-hplc method for simultaneous estimation of rosuvastatin calcium and fenofibrate in bulk and pharmaceutical dosage forms","volume":"3","author":"Thriveni","year":"2013","journal-title":"IJRPC"},{"key":"10.1016\/bs.podrm.2025.12.004_bib182","unstructured":"View of Hptlc method for simultaneous determination of rosuvastatin and fenofibrtae in bulk and pharmaceutical formulation.\u00a0https:\/\/journals.innovareacademics.in\/index.php\/ijpps\/article\/view\/2010\/9982 (Accessed 24 December\u00a02024)."},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib183","doi-asserted-by":"crossref","DOI":"10.1186\/s43094-021-00369-2","article-title":"Stability-indicating RP-HPLC method development and validation for simultaneous estimation of telmisartan and rosuvastatin calcium in bulk and in tablet dosage form","volume":"7","author":"Gholve","year":"2021","journal-title":"Futur. J. Pharm. Sci."},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib184","doi-asserted-by":"crossref","first-page":"451","DOI":"10.36468\/pharmaceutical-sciences.794","article-title":"Development and validation of a reversed-phase high performance liquid chromatography method for the simultaneous estimation of rosuvastatin calcium and telmisartan in fixed-dose complex dual-layer tablets in six dosage forms","volume":"83","author":"Choi","year":"2021","journal-title":"Indian. J. Pharm. Sci."},{"key":"10.1016\/bs.podrm.2025.12.004_bib185","unstructured":"Method development and validation for simultaneous estimation of rosuvastatin calcium and telmisartan in combined dosage form by high performance thin layer chromatography | request PDF.\u00a0https:\/\/www.researchgate.net\/publication\/279184226_Method_Development_and_Validation_for_Simultaneous_Estimation_of_Rosuvastatin_Calcium_and_Telmisartan_in_Combined_Dosage_Form_by_High_Performance_Thin_Layer_Chromatography (Accessed 24 December\u00a02024)."},{"issue":"01","key":"10.1016\/bs.podrm.2025.12.004_bib186","article-title":"Development of RP-HPLC method for the simultaneous estimation of rosuvastatin calcium and telmisartan in bulk and pharmaceutical formulations","volume":"s4","author":"Jing Zheng","year":"2013","journal-title":"J. Anal. Bioanal. Tech"},{"key":"10.1016\/bs.podrm.2025.12.004_bib187","unstructured":"Validated RP-HPLC method for simultaneous estimation of rosuvastatin and telmisartan in bulk and pharmaceutical dosage form\u00a0https:\/\/www.researchgate.net\/publication\/323780409_Validated_RP-HPLC_method_for_simultaneous_estimation_of_rosuvastatin_and_telmisartan_in_bulk_and_pharmaceutical_dosage_form (Accessed 24 December\u00a02024)."},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib188","first-page":"252","article-title":"Validated RP-HPLC method for simultaneous estimation of Rosuvastatin Calcium and Telmisartan in pharmaceutical dosage form","volume":"2","author":"Doshi","year":"2010","journal-title":"J. Chem. Pharm. Res."},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib189","doi-asserted-by":"crossref","first-page":"763","DOI":"10.13005\/ojc\/390329","article-title":"Quality by design based development and quantification of telmisartan and rosuvastatin calcium using RP-HPLC","volume":"39","author":"G. Garg","year":"2023","journal-title":"Orient. J. Chem"},{"key":"10.1016\/bs.podrm.2025.12.004_bib190","unstructured":"View of validated RP-HPLC method for simultaneous determination of rosuvastatin calcium and ezetimibe in pharmaceutical dosage form https:\/\/journals.innovareacademics.in\/index.php\/ijpps\/article\/view\/3989\/pdf_716 (Accessed 09 July\u00a02024)."},{"issue":"4","key":"10.1016\/bs.podrm.2025.12.004_bib191","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1093\/jaoac\/93.4.1222","article-title":"Determination of rosuvastatin and ezetimibe in a combined tablet dosage form using high-performance column liquid chromatography and high-performance thin-layer chromatography","volume":"93","author":"Varghese","year":"2010","journal-title":"J. AOAC Int."},{"issue":"6","key":"10.1016\/bs.podrm.2025.12.004_bib192","doi-asserted-by":"crossref","first-page":"110","DOI":"10.25166\/IJPPR.2024.30.6.09","article-title":"Simultaneous quantification of rosuvastatin calcium and ezetimibe in combined tablet dosage form using HPTLC method","volume":"30","author":"R.S","year":"2024","journal-title":"Int. J. Pharm. Pharm. Res."},{"key":"10.1016\/bs.podrm.2025.12.004_bib193","unstructured":"Micellar liquid chromatographic method development for determination of rosuvastatin calcium and ezetimibe in pharmaceutical combination dosage form | Abstract https:\/\/www.derpharmachemica.com\/abstract\/micellar-liquid-chromatographic-method-development-for-determination-of-rosuvastatin-calcium-and-ezetimibe-in-pharmaceut-3483.html (Accessed 25 Decemer\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2024.111418","article-title":"Simultaneous determination of rosuvastatin calcium and bempedoic acid in fixed-dose combination pharmaceutical dosage forms using RP-HPLC method","volume":"205","author":"Hadawale","year":"2024","journal-title":"Microchem. J."},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib195","first-page":"275","article-title":"The analytical method for the simultaneous estimation of rosuvastatin and bempedoic acid by RP-HPLC method","volume":"29","author":"Mohd","year":"2023","journal-title":"Int J. Pharm Pharm Res."},{"key":"10.1016\/bs.podrm.2025.12.004_bib196","unstructured":"Toxicology-focused development and validation of an RP-HPLC technique for quantifying bempefoic acid and rosuvastatin in a fixed-dose combination RRJoT.\u00a0https:\/\/journals.stmjournals.com\/rrjot\/article=2024\/view=156740\/ (Accessed 25 December\u00a02024)."},{"issue":"6","key":"10.1016\/bs.podrm.2025.12.004_bib197","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/jccs.201000190","article-title":"Simultaneous determination of prazosin, atorvastatin, rosuvastatin and simvastatin in API, dosage formulations and human serum by RP-HPLC","volume":"57","author":"Sultana","year":"2010","journal-title":"J. Chin. Chem. Soc."},{"issue":"5","key":"10.1016\/bs.podrm.2025.12.004_bib198","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2174\/1573411013666170127163707","article-title":"A robust QBD based high-performance thin-layer chromatographic method for the estimation of aspirin, clopidogrel bisulphate and rosuvastatin calcium in a pharmaceutical formulation using experimental design","volume":"13","author":"Sankar","year":"2017","journal-title":"Curr. Anal. Chem"},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib199","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4067\/S0717-97072010000200010","article-title":"Simultaneous determination of ceftriaxone sodium and statin drugs in pharmaceutical formulations and human serum by rp-hplc","volume":"55","author":"Sultana","year":"2010","journal-title":"J. Chil. Chem. Soc."},{"issue":"10","key":"10.1016\/bs.podrm.2025.12.004_bib200","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/cjoc.201090333","article-title":"High-performance liquid chromatographic analysis of pioglitazone, gliquidone, rosuvastatin and simvastatin in formulations and human serum","volume":"28","author":"Arayne","year":"2010","journal-title":"Chin. J. Chem"},{"key":"10.1016\/bs.podrm.2025.12.004_bib201","unstructured":"(PDF) Development and validation of a stability-indicating reversed-phase HPLC method for simultaneous estimation of rosuvastatin and ezetimibe from their combination dosage forms.\u00a0https:\/\/www.researchgate.net\/publication\/277059048_Development_and_Validation_of_a_Stability-Indicating_Reversed-Phase_HPLC_Method_for_Simultaneous_Estimation_of_Rosuvastatin_and_Ezetimibe_from_Their_Combination_Dosage_Forms (Accessed 11 July\u00a02024)."},{"issue":"07","key":"10.1016\/bs.podrm.2025.12.004_bib202","doi-asserted-by":"crossref","DOI":"10.4172\/2155-9872.1000154","article-title":"An ultra-sensitive LC method for simultaneous determination of rosuvastatin, alprazolam and diclofenac sodium in API, pharmaceutical formulations and human serum by programming the detector","volume":"03","author":"Sultana","year":"2012","journal-title":"J. Anal. Bioanal. Tech"},{"issue":"4","key":"10.1016\/bs.podrm.2025.12.004_bib203","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.4067\/S0717-97072013000400059","article-title":"LC determination of rosuvastatin and ezetimibe in human plasma","volume":"58","author":"Ashfaq","year":"2013","journal-title":"J. Chil. Chem. Soc."},{"key":"10.1016\/bs.podrm.2025.12.004_bib204","unstructured":"Simultaneous quantitation and monitoring of gemifloxacin and rosuvastatin by liquid chromatography with Uv-detection. https:\/\/www.journalijar.com\/article\/3442\/simultaneous-quantitation-and-monitoring-of-gemifloxacin-and-rosuvastatin-by-liquid-chromatography-with-uv-detection\/ (Accessed 11 July 2024)."},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib205","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/bmc.561","volume":"20","author":"Pasha","year":"2006","journal-title":"Biomed. Chromatogr"},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib206","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/0250-474X.32127","article-title":"Determination of simvastatin, pravastatin sodium and rosuvastatin calcium in tablet dosage forms by HPTLC","volume":"69","author":"Chaudhari","year":"2007","journal-title":"Indian. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib207","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/22297928.2015.1062419","article-title":"Simultaneous determination of cetirizine, atorvastatin, simvastatin, rosuvastatin or pravastatin in formulations and human serum by RP-HPLC","volume":"5","author":"Shamshad","year":"2015","journal-title":"Anal. Chem. Lett"},{"key":"10.1016\/bs.podrm.2025.12.004_bib208","unstructured":"Optimization of RPLC conditions for quantitative analysis of atorvastatin and rosuvastatin in pharmaceutical dosage form | request PDF.\u00a0https:\/\/www.researchgate.net\/publication\/323254340_Optimization_of_RPLC_Conditions_for_Quantitative_Analysis_of_Atorvastatin_and_Rosuvastatin_in_Pharmaceutical_Dosage_Form (Accessed 12 July\u00a02024)."},{"key":"10.1016\/bs.podrm.2025.12.004_bib209","unstructured":"(PDF) Development and validation of a sensitive and accurate method for determination of atorvastatin and rosuvastatin in rat plasma by reversedphase high performance liquid chromatography with uv detection.\u00a0https:\/\/www.researchgate.net\/publication\/325312777_DEVELOPMENT_AND_VALIDATION_OF_A_SENSITIVE_AND_ACCURATE_METHOD_FOR_DETERMINATION_OF_ATORVASTATIN_AND_ROSUVASTATIN_IN_RAT_PLASMA_BY_REVERSEDPHASE_HIGH_PERFORMANCE_LIQUID_CHROMATOGRAPHY_WITH_UV_DETECTION (Accessed 12 July\u00a02024)."},{"issue":"30","key":"10.1016\/bs.podrm.2025.12.004_bib210","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1016\/j.jchromb.2011.09.021","article-title":"Simultaneous determination of timolol maleate, rosuvastatin calcium and diclofenac sodium in pharmaceuticals and physiological fluids using HPLC-UV","volume":"879","author":"Nasir","year":"2011","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci."},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib211","article-title":"Simultaneous estimation of rosuvastatin and amlodipine in pharmaceutical formulations using stability indicating HPLC method","volume":"50","author":"Ashfaq","year":"2014","journal-title":"Artic. Braz. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/bs.podrm.2025.12.004_bib212","first-page":"2789","article-title":"Development and validation of a RP-HPLC-PDA method for simultaneous determination of Rosuvastatin calcium and Amlodipine besylate in pharmaceutical dosage form","author":"Tajane","year":"2012","journal-title":"J. Chem. Pharm. Res."},{"issue":"10","key":"10.1016\/bs.podrm.2025.12.004_bib213","doi-asserted-by":"crossref","first-page":"50","DOI":"10.22159\/ijpps.2018v10i10.28329","article-title":"Development and validation of stability indicating rp-hplc method for simultaneous determination of aspirin, rosuvastatin, clopidogrel in bulk and pharmaceutical dosage form","volume":"10","author":"Pisal","year":"2018","journal-title":"Int. J. Pharm. Pharm. Sci."},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib214","doi-asserted-by":"crossref","first-page":"151","DOI":"10.5530\/ijper.52.1.17","article-title":"Development of rapid and validated RP-HPLC method for concurrent quantification of rosuvastatin and aspirin form solid dosage form","volume":"52","author":"Attimarad","year":"2018","journal-title":"Indian. J. Pharm. Educ. Res."},{"issue":"4","key":"10.1016\/bs.podrm.2025.12.004_bib215","doi-asserted-by":"crossref","first-page":"79","DOI":"10.22270\/jddt.v10i4.4203","article-title":"Development and validation of stability-indicating assay method by RP-HPLC for simultaneous estimation of rosuvastatin calcium and fenofibrate in pharmaceutical dosage form","volume":"10","author":"Pimpale","year":"2020","journal-title":"J. Drug. Deliv. Ther"},{"issue":"6","key":"10.1016\/bs.podrm.2025.12.004_bib216","first-page":"850","article-title":"Analytical method development and validation for the simultaneous estimation of rosuvastatin and fenofibrate in tablet dosage form by reverse-phase high-performance liquid chromatography","volume":"1","author":"Sumalatha","year":"2013","journal-title":"Indian J. Res. Pharm. Biotechnol."},{"issue":"8","key":"10.1016\/bs.podrm.2025.12.004_bib217","first-page":"846","article-title":"A new rp-hplc method development and validation of for the simultaneous estimation of rosuvastatin calcium and fenofibrate in tablet dosage form","volume":"3","author":"Anuradha","year":"2016","journal-title":"IAJPS"},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib218","doi-asserted-by":"crossref","first-page":"343","DOI":"10.25258\/ijpqa.11.3.7","article-title":"Novel isocratic rp-hplc method development and validation of rosuvastatin and fenofibrate in tablets","volume":"11","author":"Kudupudi","year":"2020","journal-title":"Int. J. Pharm. Qual. Assur"},{"issue":"06","key":"10.1016\/bs.podrm.2025.12.004_bib219","doi-asserted-by":"crossref","DOI":"10.4172\/2157-7064.1000252","article-title":"Development of a validated RP-HPLC method for simultaneous estimation of metformin hydrochloride and rosuvastatin calcium in bulk and in-house formulation","volume":"05","author":"TGK","year":"2014","journal-title":"J. Chromatogr. Sep. Tech"},{"key":"10.1016\/bs.podrm.2025.12.004_bib220","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.talanta.2018.02.068","article-title":"Development and validation of a hydrophilic interaction liquid chromatography method for the quantitation of impurities in fixed-dose combination tablets containing rosuvastatin and metformin","volume":"183","author":"Machairas","year":"2018","journal-title":"Talanta"},{"issue":"4","key":"10.1016\/bs.podrm.2025.12.004_bib221","first-page":"405","article-title":"Stability indicating liquid chromatographic method for the simultaneous determination of rosuvastatin and ezetimibe in pharmaceutical formulations","volume":"4","author":"Mukthinuthalapati","year":"2014","journal-title":"Adv. Pharm. Bull"},{"issue":"6","key":"10.1016\/bs.podrm.2025.12.004_bib222","first-page":"44","article-title":"Development and validation of RP-HPLC method for the estimation of rosuvastatin calcium and niacin in combined tablet dosage form","volume":"4","author":"Savita","year":"2015","journal-title":"Int. J. Pharma Res. Rev."},{"key":"10.1016\/bs.podrm.2025.12.004_bib223","unstructured":"(PDF) Development and Validation of RP-HPLC method for simultaneous determination of rosuvastatin and clopidogrel in tablet dosage form.\u00a0https:\/\/www.researchgate.net\/publication\/321780080_Development_and_Validation_of_RP-HPLC_Method_For_Simultaneous_Determination_Of_Rosuvastatin_And_Clopidogrel_In_Tablet_Dosage_Form (Accessed 12 July\u00a02024)."},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib224","first-page":"219","article-title":"Development and validation of bio-analytical Rp-Ultra fast liquid chromatographic method for simultaneous estimation of clopidogrel and rosuvastatin in human plasma","volume":"6","author":"Nagavi","year":"2015","journal-title":"Int J Pharm Sci Res"},{"key":"10.1016\/bs.podrm.2025.12.004_bib225","doi-asserted-by":"crossref","first-page":"84","DOI":"10.22159\/ajpcr.2020.v13i9.38013","article-title":"Stability-indicating method development and validation for the simultaneous estimation of rosuvastatin calcium and clopidogrel bisulfate in pharmaceutical dosage form by reverse-phase high-performance liquid chromatography","author":"PIMPALE","year":"2020","journal-title":"Asian J. Pharm. Clin. Res."},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib226","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1590\/S0100-40422011000200015","article-title":"Development and validation of a stability-indicating uplc method for rosuvastatin and its related impurities in pharmaceutical dosage forms","volume":"34","author":"Venkat","year":"2011","journal-title":"Quim. Nov."},{"key":"10.1016\/bs.podrm.2025.12.004_bib227","doi-asserted-by":"crossref","unstructured":"C. Drugs, F. Sciences, Determination of rosuvastatin in the presence of its degradation products by a stability-indicating LC method, Accessed\u00a019 July\u00a02024. [Online]. Available: https:\/\/academic.oup.com\/jaoac\/article\/88\/4\/1142\/5657404.","DOI":"10.1093\/jaoac\/88.4.1142"},{"issue":"4","key":"10.1016\/bs.podrm.2025.12.004_bib228","doi-asserted-by":"crossref","first-page":"175","DOI":"10.5958\/2231-5691.2015.00027.1","article-title":"A new simultaneous determination of rosuvastatin calcium and its lactone impurity by reverse phase HPLC method","volume":"5","author":"Moodbidri","year":"2015","journal-title":"Asian J. Pharm. Res."},{"key":"10.1016\/bs.podrm.2025.12.004_bib229","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115636","article-title":"Insight into the photolytic degradation products of rosuvastatin: full chiral and structural elucidation and conversion kinetics by a combined chromatographic, spectroscopic and theoretical approach","volume":"236","author":"Borioni","year":"2023","journal-title":"J. Pharm. Biomed. Anal"},{"key":"10.1016\/bs.podrm.2025.12.004_bib230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.aca.2020.08.008","article-title":"Multiblock modelling on the study of the kinetic degradation of rosuvastatin calcium in the presence of retention time shifts and rank deficiency","volume":"1133","author":"Pinto","year":"2020","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/bs.podrm.2025.12.004_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115239","article-title":"Chemo- and enantio-selective reversed-phase HPLC analysis of rosuvastatin using a cellulose-based chiral stationary phase in gradient elution mode","volume":"225","author":"Mammone","year":"2023","journal-title":"J. Pharm. Biomed. Anal"},{"issue":"1","key":"10.1016\/bs.podrm.2025.12.004_bib232","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/molecules28010431","article-title":"A novel validated UHPLC method for the estimation of rosuvastatin and its complete impurity profile in tablet formulations","volume":"28","author":"Mammone","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/bs.podrm.2025.12.004_bib233","doi-asserted-by":"crossref","first-page":"968","DOI":"10.17344\/acsi.2017.3662","article-title":"Optimization of UPLC method for simultaneous determination of rosuvastatin and rosuvastatin degradation products","volume":"64","author":"Zakraj\u0161ek","year":"2017","journal-title":"Acta Chim. Slov"},{"key":"10.1016\/bs.podrm.2025.12.004_bib234","unstructured":"(PDF) Simple and rapid determination of rosuvastatin in human plasma by LC-MS\/MS. https:\/\/www.researchgate.net\/publication\/370466727_SIMPLE_AND_RAPID_DETERMINATION_OF_ROSUVASTATIN_IN_HUMAN_PLASMA_BY_LC-MSMS (Accessed 25\u00a0December\u00a02024)."},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib235","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jpba.2006.12.022","article-title":"Quantitative determination of rosuvastatin in human plasma by ion pair liquid-liquid extraction using liquid chromatography with electrospray ionization tandem mass spectrometry","volume":"44","author":"Lan","year":"2007","journal-title":"J. Pharm. Biomed. Anal"},{"issue":"16","key":"10.1016\/bs.podrm.2025.12.004_bib236","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/rcm.2542","article-title":"Quantitative determination of rosuvastatin in human plasma by liquid chromatography with electrospray ionization tandem mass spectrometry","volume":"20","author":"Xu","year":"2006","journal-title":"Rapid Commun. Mass. Spectrom"},{"issue":"11","key":"10.1016\/bs.podrm.2025.12.004_bib237","first-page":"705","article-title":"Development and validation of a highly sensitive and robust LC-MS\/MS with electrospray ionization method for quantification of rosuvastatin in small volume human plasma samples and its application to a clinical study","volume":"57","author":"Kallem","year":"2007","journal-title":"Arzneimittelforschung"},{"issue":"4","key":"10.1016\/bs.podrm.2025.12.004_bib238","doi-asserted-by":"crossref","first-page":"341","DOI":"10.4236\/pp.2011.24044","article-title":"Validated LC-MS\/MS method for the determination of rosuvastatin in human plasma: application to a bioequivalence study in Chinese volunteers","volume":"2","author":"Zhang","year":"2011","journal-title":"Pharmacol. &\u00a0Pharm"},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib239","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jchromb.2005.12.040","article-title":"Application of microbore HPLC in combination with tandem MS for the quantification of rosuvastatin in human plasma","volume":"832","author":"Oudhoff","year":"2006","journal-title":"J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci."},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib240","doi-asserted-by":"crossref","first-page":"529","DOI":"10.4155\/bio.09.47","article-title":"Automated liquid-liquid extraction method for high-throughput analysis of rosuvastatin in human EDTA K2 plasma by LC-MS\/MS","volume":"1","author":"Hussain","year":"2009","journal-title":"Bioanalysis"},{"key":"10.1016\/bs.podrm.2025.12.004_bib241","unstructured":"Estimation and validation for determination of rosuvastatin in human plasma by lc\/ms\/ms method, Accessed\u00a018 July\u00a02024. [Online]. Available: www.jgtps.com."},{"issue":"5","key":"10.1016\/bs.podrm.2025.12.004_bib242","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1590\/S0103-50532005000600009","article-title":"Estimation of rosuvastatin in human plasma by HLPC tandem mass spectroscopic method and its application to bioequivalence study","volume":"16","author":"Singh","year":"2005","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/bs.podrm.2025.12.004_bib243","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/9952318","article-title":"Development and validation of analytical procedure for elemental impurities in rosuvastatin calcium tablets by ICP-MS and microwave digestion","volume":"2024","author":"Hao","year":"2024","journal-title":"J. Anal. Methods Chem"},{"issue":"6","key":"10.1016\/bs.podrm.2025.12.004_bib244","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jare.2014.08.010","article-title":"Simultaneous determination of rosuvastatin and amlodipine in human plasma using tandem mass spectrometry: application to disposition kinetics","volume":"6","author":"Narapusetti","year":"2015","journal-title":"J. Adv. Res."},{"key":"10.1016\/bs.podrm.2025.12.004_bib245","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.chroma.2017.01.084","article-title":"High resolution mass spectrometry based method applicable for a wide range of 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibitors in blood serum including intermediates and products of the cholesterol biosynthetic pathway","volume":"1489","author":"Kosek","year":"2017","journal-title":"J. Chromatogr. A"},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib246","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5740\/jaoacint.11-117","article-title":"Development and validation of a liquid chromatography\/ mass spectrometry method for the simultaneous quantitation of rosuvastatin and ezetimibe in human plasma","volume":"96","author":"Varghese","year":"2013","journal-title":"J. AOAC Int."},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib247","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/2231-4040.157982","article-title":"Development, validation of liquid chromatography-tandem mass spectrometry method for simultaneous determination of rosuvastatin and metformin in human plasma and its application to a pharmacokinetic study","volume":"6","author":"Kumar","year":"2015","journal-title":"J. Adv. Pharm. Technol. Res."},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib248","doi-asserted-by":"crossref","first-page":"125","DOI":"10.12793\/tcp.2021.29.e13","article-title":"Validation of LC-MS\/MS method for determination of rosuvastatin concentration in human blood collected by volumetric absorptive microsampling (VAMS)","volume":"29","author":"Moon","year":"2021","journal-title":"Transl. Clin. Pharmacol"},{"key":"10.1016\/bs.podrm.2025.12.004_bib249","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jpba.2019.05.069","article-title":"An LC\u2013MS\/MS spectrometry method for the simultaneous determination of rosuvastatin and Irbesartan in rat plasma: insight into pharmacokinetic and drug-drug interaction studies","volume":"174","author":"Elgawish","year":"2019","journal-title":"J. Pharm. Biomed. Anal"},{"issue":"7","key":"10.1016\/bs.podrm.2025.12.004_bib250","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5093","article-title":"UPLC\u2013MS\/MS method for the simultaneous quantification of pravastatin, fexofenadine, rosuvastatin, and methotrexate in a hepatic uptake model and its application to the possible drug\u2013drug interaction study of triptolide","volume":"35","author":"Wu","year":"2021","journal-title":"Biomed. Chromatogr"},{"key":"10.1016\/bs.podrm.2025.12.004_bib251","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2019.121733","article-title":"UHPLC-MS\/MS assay for simultaneous determination of amlodipine, metoprolol, pravastatin, rosuvastatin, atorvastatin with its active metabolites in human plasma, for population-scale drug-drug interactions studies in people living with HIV","volume":"1125","author":"Courlet","year":"2019","journal-title":"J. Chromatogr. B"},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib252","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jpba.2003.12.022","article-title":"Quantification of the N-desmethyl metabolite of rosuvastatin in human plasma by automated SPE followed by HPLC with tandem MS detection","volume":"35","author":"Hull","year":"2004","journal-title":"J. Pharm. Biomed. Anal"},{"issue":"6","key":"10.1016\/bs.podrm.2025.12.004_bib253","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1055\/s-0043-123576","article-title":"Simultaneous determination of rosuvastatin, rosuvastatin-5 S-lactone, and N-desmethyl rosuvastatin in human plasma by UPLC-MS\/MS and its application to clinical study","volume":"68","author":"Bai","year":"2018","journal-title":"Drug. Res. (Stuttg)."},{"issue":"11","key":"10.1016\/bs.podrm.2025.12.004_bib254","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/bmc.2944","article-title":"Development and validation of a sensitive method for simultaneous determination of rosuvastatin and N-desmethyl rosuvastatin in human plasma using liquid chromatography\/negative electrospray ionization\/tandem mass spectrometry","volume":"27","author":"Lee","year":"2013","journal-title":"Biomed. Chromatogr"},{"issue":"8","key":"10.1016\/bs.podrm.2025.12.004_bib255","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/10826076.2014.982866","article-title":"Determination of rosuvastatin and its metabolite N-desmethyl rosuvastatin in human plasma by liquid chromatography-high resolution mass spectrometry: method development, validation, and application to pharmacokinetic study","volume":"38","author":"Shah","year":"2015","journal-title":"J. Liq. Chromatogr. Relat. Technol"},{"issue":"3","key":"10.1016\/bs.podrm.2025.12.004_bib256","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00216-011-5548-4","article-title":"A simple assay for the simultaneous determination of rosuvastatin acid, rosuvastatin-5S-lactone, and N-desmethyl rosuvastatin in human plasma using liquid chromatography-tandem mass spectrometry (LC-MS\/MS)","volume":"402","author":"MacWan","year":"2012","journal-title":"Anal. Bioanal. Chem"},{"issue":"2","key":"10.1016\/bs.podrm.2025.12.004_bib257","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/separations9020040","article-title":"Simultaneous quantification of vitamin A and derivatives in cosmetic products by liquid chromatography with ultraviolet detection","volume":"9","author":"V\u00e1llez\u2010gomis","year":"2022","journal-title":"Separations"},{"issue":"19","key":"10.1016\/bs.podrm.2025.12.004_bib258","doi-asserted-by":"crossref","first-page":"2300435","DOI":"10.1002\/jssc.202300435","article-title":"Simultaneous determination of six \u03b1\u2011dicarbonyl compounds in traditional Chinese medicines using high-performance liquid chromatography-fluorescence detector with pre-column derivatization","volume":"46","author":"Xu","year":"2023","journal-title":"J. Sep. Sci."},{"issue":"5","key":"10.1016\/bs.podrm.2025.12.004_bib259","doi-asserted-by":"crossref","DOI":"10.3390\/toxins14050328","article-title":"Overview of recent liquid chromatography mass spectrometry-based methods for natural toxins detection in food products","volume":"14","author":"De Girolamo","year":"2022","journal-title":"Toxins (Basel)"}],"container-title":["Profiles of Drug Substances, Excipients and Related Methodology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871512525000160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871512525000160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T02:10:37Z","timestamp":1771726237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871512525000160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443432408"],"references-count":259,"URL":"https:\/\/doi.org\/10.1016\/bs.podrm.2025.12.004","relation":{},"ISSN":["1871-5125"],"issn-type":[{"value":"1871-5125","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}